Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9)

  1. Pozzilli, P.
  2. Norwood, P.
  3. Jódar, E.
  4. Davies, M.J.
  5. Ivanyi, T.
  6. Jiang, H.
  7. Woodward, D.B.
  8. Milicevic, Z.
Aldizkaria:
Diabetes, Obesity and Metabolism

ISSN: 1463-1326,  1462-8902

Argitalpen urtea: 2017

Alea: 19

Zenbakia: 7

Orrialdeak: 1024-1031

Mota: Artikulua

DOI: 10.1111/DOM.12937 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus